Antisense therapy of hepatitis B virus infection

Molecular Biotechnology
W B OffenspergerH E Blum

Abstract

Chronic infection with the hepatitis B virus (HBV) is a major health problem worldwide. The only established therapy is interferon-a with an efficacy of only 30-40% in highly selected patients. The discovery of animal viruses closely related to the HBV has contributed to active research on antiviral therapy of chronic hepatitis B. The animal model tested and described in this article are Peking ducks infected with the duck hepatitis B virus (DHBV). Molecular therapeutic strategies aimed at blocking gene expression include antisense DNA. An antisense oligodeoxynucleotide directed against the 5'-region of the preS gene of DHBV inhibited viral replication and gene expression in vitro in primary duck hepatocytes and in vivo in Peking ducks. These results demonstrate the potential clinical use of antisense DNA as antiviral therapeutics.

References

Jan 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·P C Zamecnik, M L Stephenson
Sep 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·J SummersR Snyder
Nov 27, 1992·Science·J C HanveyK G Au
May 1, 1992·Trends in Biotechnology·S Agrawal
Aug 1, 1992·Trends in Biotechnology·E Wickstrom
May 8, 1992·Science·W F Anderson
Sep 5, 1991·The New England Journal of Medicine·J R Wands, H E Blum
Jun 21, 1990·Biochimica Et Biophysica Acta·C Hélène, J J Toulmé
Jan 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·M A KayW Pokorny
Jan 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·G Duval-ValentinC Hélène
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C Hélène
Apr 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·J P LeonettiB Lebleu
Apr 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J P LeonettiL Leserman
May 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·E WagnerM L Birnstiel
Mar 1, 1987·Journal of Virology·L J Chang, C M Stoltzfus
Aug 1, 1989·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·I FourelC Trepo
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·P L FelgnerM Danielsen
Oct 10, 1985·Nature·P TiollaisA Dejean
May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·C C SmithP O Ts'o
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·P C ZamecnikP S Sarin
Feb 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M LemaitreB Lebleu
Oct 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·S AgrawalP C Zamecnik
Nov 15, 1988·Biochemical and Biophysical Research Communications·S SuzukiD L Tyrrell
Jun 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·D K FerrisW L Farrar
Oct 1, 1988·Journal of Virology·R SprengelH Will
Aug 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·F D LedleyS L Woo
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M MatsukuraS Broder
Jan 1, 1987·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K HirotaK Okuda
May 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·P L MarionW S Robinson
Jan 15, 1994·Annals of Internal Medicine·D D Ma, T L Doan

❮ Previous
Next ❯

Citations

Jun 7, 2000·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·I LebedevaM Vilenchik
Dec 15, 2015·Journal of Hepatology·Gaetan BillioudStefan Wieland
Sep 25, 1999·Journal of Cellular Physiology·U GalderisiA Giordano
Sep 2, 2000·The Journal of Biological Chemistry·L GormanR Kole
May 4, 2007·Journal of the Chinese Medical Association : JCMA·Chun-Jen Liu, Jia-Horng Kao
Jun 19, 2015·Police Practice & Research : an International Journal·Jennifer D WoodJerry H Ratcliffe
Aug 27, 1999·Biochemical and Biophysical Research Communications·T HanafusaT Tsuji

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.